Select a community
Devic's
Find out more about the PatientsLikeMe
Devic's Community
Home > Community Treatment Reports > IVIg Intravenous Immuno Globulin Treatment Report
What is IVIg Intravenous Immuno Globulin?

Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immune disorders including myaesthenia gravis and multifocial motor neuropathy. It is sometimes trialed on ALS patients during the diagnostic process to rule out other illnesses. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Support another treatment 2 0
stop relapse 1 1
Prolong new syptoms of Devic's. 1 0
Slow my Devic's progress 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
1 100%

Dosages

  1 g monthly 1 g daily 330 mcg monthly 500 mL monthly
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking IVIg Intravenous Immuno Globulin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 50% Did not seem to work: 50%
Side effects too severe
1 50% Side effects too severe: 50%

See all 2 patients who’ve stopped taking IVIg Intravenous Immuno Globulin

Currently Taking IVIg Intravenous Immuno Globulin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
0
0
1
0

Stopped Taking IVIg Intravenous Immuno Globulin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 100%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.